Fecal Level of Calprotectin Identifies Histologic Inflammation inPatients With Ulcerative Colitis in Clinical and Endoscopic Remission

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 11, 2014, Pages 1865-1870

  Guardiola, Jordi ^a   Lobatón, Triana ^a   Rodríguez Alonso, Lorena ^a   Ruiz Cerulla, Alexandra ^a   Arajol, Claudia ^a   Loayza, Carolina ^a   Sanjuan, Xavier ^a   Sánchez, Elena ^a   Rodríguez Moranta, Francisco ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

Deep Remission; Histologic Remission; IBD; Mucosal Healing

Indexed keywords

CALGRANULIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; CELL INFILTRATION; COLON BIOPSY; COLONOSCOPY; CRYPT CELL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDY; FECES LEVEL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PROSPECTIVE STUDY; REMISSION; ULCERATIVE COLITIS; ADOLESCENT; AGED; BIOPSY; CHEMISTRY; COLITIS, ULCERATIVE; CYTOCHEMISTRY; FECES; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOMARKERS; BIOPSY; COLITIS, ULCERATIVE; COLONOSCOPY; FECES; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84908238365     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.06.020     Document Type: Article

References (24)

1. D'Haens G., Sandborn W.J., Feagan B.G., et al. Areview of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007, 132:763-786.
2. Froslie K.F., Jahnsen J., Moum B.A., et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007, 133:412-422.
3. Meucci G., Fasoli R., Saibeni S., et al. Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: a prospective, multicenter study. Inflamm Bowel Dis 2012, 18:1006-1010.
4. Truelove S.C., Richards W.C.D. Biopsy studies in ulcerative colitis. Br Med J 1956, i:1315-1318.
5. Baars J.E., Nuij V.J., Oldenburg B., et al. Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation. Inflamm Bowel Dis 2012, 18:1634-1640.
6. Rosenberg L., Nanda K.S., Zenlea T., et al. Histologic markers of inflammation in patients with ulcerative colitis in clinical remission. Clin Gastroenterol Hepatol 2013, 11:991-996.
7. Riley S.A., Mani V., Goodman M.J., et al. Microscopic activity in ulcerative colitis: what does it mean?. Gut 1991, 32:174-178.
8. Bitton A., Peppercorn M.A., Antonioli D.A., et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology 2001, 120:13-20.
9. Bessissow T., Lemmens B., Ferrante M., et al. Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing. Am J Gastroenterol 2012, 107:1684-1692.
10. Rutter M., Saunders B., Wilkinson K., et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004, 126:451-459.
11. Rubin D.T., Huo D., Kinnucan J.A., et al. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study. Clin Gastroenterol Hepatol 2013, 11:1601-1608.
12. Røseth A.G., Aadland E., Jahnsen J., et al. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 1997, 58:176-180.
13. Lobatón T., Rodríguez-Moranta F., Lopez A., et al. Anew rapid quantitative test for fecal calprotectin predicts endoscopic activity in ulcerative colitis. Inflamm Bowel Dis 2013, 19:1034-1042.
14. Lobatón T., López-García A., Rodríguez-Moranta F., et al. Anew rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease. JCrohns Colitis 2013, 7:e641-e651.
15. Schoepfer A.M., Beglinger C., Straumann A., et al. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Am J Gastroenterol 2010, 105:162-169.
16. Schoepfer A.M., Beglinger C., Straumann A., et al. Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflamm Bowel Dis 2009, 15:1851-1858.
17. Colombel J.F., Rutgeerts P., Reinisch W., et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology 2011, 141:1194-1201.
18. Costa F., Mumolo M.G., Ceccarelli L., et al. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut 2005, 54:364-368.
19. Gisbert J.P., Bermejo F., Perez-Calle J.L., et al. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflamm Bowel Dis 2009, 15:1190-1198.
20. Osada T., Ohkusa T., Okayasu I., et al. Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis. JGastroenterol Hepatol 2008, 23(Suppl 2):S262-S267.
21. Lemmens B., Arijs I., Van Assche G., et al. Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitis. Inflamm Bowel Dis 2013, 19:1194-1201.
22. Daperno M., Castiglione F., Ridder L., et al. Results of the 2nd part Scientific Workshop of the ECCO. II: measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease. JCrohns Colitis 2011, 5:484-498.
23. Bernstein C.N., Shanahan F., Anton P.A., et al. Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study. Gastrointest Endosc 1995, 42:232-237.
24. Geboes K., Riddell R., Öst A., et al. Areproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 2000, 47:404-409.